We are live on ! Find out more
BCM

BML Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 129.82%
This Fund
S&P 500
This Quarter Est. Return
+28.58%
1 Year Est. Return
+129.82%
3 Year Est. Return
+394.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$156M
AUM Growth
+$40.1M
Cap. Flow
+$10.8M
Cap. Flow %
6.95%
Top 10 Hldgs %
94.02%
Holding
19
New
3
Increased
3
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$5.57M
2
TLYS icon
Tilly's
TLYS
+$4.34M
3
KHC icon
Kraft Heinz
KHC
+$2.94M
4
JANX icon
Janux Therapeutics
JANX
+$2.12M
5
IMA
ImageneBio Inc
IMA
+$154K

Top Sells

Rank Stock Value
1
AVIR icon
Atea Pharmaceuticals
AVIR
+$1.98M
2
LSTA icon
Lisata Therapeutics
LSTA
+$136K

Sector Composition

Rank Sector Weight
1 Healthcare 85.34%
2 Consumer Discretionary 9.73%
3 Consumer Staples 4.72%

No holdings matched the selected filter criteria.

Similar funds

AIS
Accredited Investor Services St. Cloud, Minnesota $156M AUM 21.61% 1-Year Est. Return
BWM
BNB Wealth Management Silver Spring, Maryland $156M AUM
CFG
Cornerstone Financial Group Omaha, Nebraska $156M AUM 12% 1-Year Est. Return
IWA
Invera Wealth Advisors Bend, Oregon $156M AUM 22.76% 1-Year Est. Return
PFO
Pioneer Family Office North Miami Beach, Florida $156M AUM
BCM
Bluefin Capital Management New York $156M AUM 18.47% 1-Year Est. Return
PMSA
Patrick M. Sweeney & Associates Libertyville, Illinois $156M AUM 19.16% 1-Year Est. Return
GSWA
Good Steward Wealth Advisors Clarksville, Tennessee $156M AUM 13.06% 1-Year Est. Return

BML Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, BML Capital Management held 19 positions worth $156M, up 35% from $116M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

BML Capital Management deployed $10.8M of net new capital in Q1 2026, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Tilly's: 2,150,000 shares worth $8.71M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 89% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Atea Pharmaceuticals, an estimated $1.98M trimmed.

  • BML Capital Management's largest Q1 2026 buy was Tilly's: 2,150,000 shares worth $8.71M.
  • BML Capital Management added most to Outset Medical in Q1 2026, an estimated $5.57M increase.
  • BML Capital Management's biggest Q1 2026 reduction was Atea Pharmaceuticals, cutting an estimated $1.98M.
  • BML Capital Management fully exited Lisata Therapeutics in Q1 2026, selling an estimated $136K.
  • BML Capital Management's ten largest holdings make up 94% of its $156M portfolio in Q1 2026.
  • BML Capital Management opened 3 new positions and closed 3 in Q1 2026.
  • BML Capital Management's portfolio value rose 35% quarter-over-quarter to $156M.

Based on BML Capital Management's 13F filing for Q1 2026, filed 6 May 2026.